Latest Cencora News & Updates

See the latest news and media coverage for Cencora. We track all announcements, press releases, and industry mentions in real time, all in one place.

Cencora

Global pharmaceutical distributor and healthcare services provider

Latest news about Cencora

April 8 Cencora

Cencora supports Türkiye’s first manned ISS journey

Cencora transports valuable research materials using expertise in temperature-sensitive shipping.
March 26 Cencora

Cencora releases report on payer trends for CGTs

It provides insights into engagement strategies, coverage processes, and evidence requirements from a survey of 154 million covered lives.
March 23 Cencora

Cencora announces acquisition of EyeSouth Partners’ retina business

The $1.1 billion deal expands Retina Consultants of America. Cencora reaffirms fiscal 2026 guidance.
March 17 Cencora

Cencora announces CFO retirement

James F. Cleary retires June 30, 2026; search firm engaged for successor. Fiscal 2026 EPS guidance reaffirmed at $17.45-$17.75.

April 27 Yahoo Finance

CareMetx Acquires U.S.-based Patient Services and Free Goods Pharmacy Operations from Cencora, Significantly Expanding Its Patient Access Platform

As demand for technology-forward patient services accelerates, combined organization positions CareMetx to deliver greater innovation for biopharma clients.BETHESDA, MD, April 27, 2026 (GLOBE NEWSWIRE) ...
April 26 MSN

Cencora invests $1B in automation and cold chain expansion

Cencora, formerly AmerisourceBergen, is investing $1 billion to expand and automate its U.S. pharmaceutical distribution network, including new high-tech centers in Ohio and California and...
April 25 FOX 45

SUN: Maryland Supreme Court vacates Baltimore’s $153M opioid verdict, sends case back

The Maryland Supreme Court on Friday wiped out Baltimore’s $153 million opioid verdict, sending the ...
April 24 Yahoo Finance

Cencora, Inc. (COR) Expands Into Retina Services Business in $1.1B Deal

Cencora, Inc. (NYSE:COR) is one of the stocks positioned for breakout growth. On March 24, UBS reiterated a Buy rating on Cencora, Inc. (NYSE:COR) with...

Never miss news about Cencora

Track Cencora and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Browse news for competitors to Cencora and other trending companies.